DHR Danaher Corporation Common Stock
NYSE · Life Sciences Tools & Services · View on SEC EDGAR ↗ close Oct 6, 2026 10-K/10-Q Jul 21, 2026DHR Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
DHR Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
| Ex-date | Split | Type |
|---|---|---|
| Oct. 2, 2023 | 141-for-125 | Forward |
| July 5, 2016 | 1319-for-1000 | Forward |
| June 14, 2010 | 2-for-1 | Forward |
| May 21, 2004 | 2-for-1 | Forward |
| June 1, 1998 | 2-for-1 | Forward |
| Jan. 23, 1995 | 2-for-1 | Forward |
| Sept. 9, 1987 | 2-for-1 | Forward |
About Danaher Corporation Common Stock Company overview from Wikipedia
Danaher Corporation is an American healthcare company headquartered in Washington, D.C.. It develops products used for advances in biotechnology, life sciences, and diagnostics. The company operates three divisions: biotechnology (28% of 2024 revenues), which develops products for the development of therapeutics; life sciences (31% of 2024 revenues), which develops products to identify causes of disease, new therapies, and to test and manufacture new drugs, vaccines and gene editing technologies; and diagnostics (41% of 2024 revenues), which develops instruments, consumables, and software and services to diagnose diseases. Danaher was founded in 1984 by brothers Steven Rales and Mitchell Rales; it was named after Danaher Creek in Western Montana, where the brothers came up with the idea for the company while fishing.
The company is ranked 180th on the Fortune 500 and 241st on the Forbes Global 2000.
History
Early years
The company's origins go back to DMG, Inc., a Massachusetts real estate investment trust organized in 1969. In 1978, DMG, Inc. was reorganized as a Florida corporation and changed its name to Diversified Mortgage Investors, Inc. In 1983, the Stephen M. Rales and Mitchell P. Rales invested in the company, which at that time was invested in retirement home developments, they then replaced the existing management in a bitter proxy battle.
In 1984, the company adopted the name Danaher and reincorporated under the Delaware General Corporation Law. The name came from a river in Montana.
In 1985, the Rales brothers offered $400 million in a hostile bid for Scott Fetzer Company but lost out to Berkshire Hathaway.
In June 1986, Danaher acquired Chicago Pneumatic in a hostile takeover, offering $60.8 million for the 32% of the company not already owned. The company had merged in July 1984 with a sister company, the Jacobs Manufacturing Co., and had purchased Matco Tools in April 1981.
In June 1987, Danaher sold Chicago Pneumatic while retaining Jacobs, including its Matco Tools Division. Jacobs' name was changed to Matco Tools Corp. In November 1991, the other divisions within Jacobs were established as separate operating companies. In January 1993, Danaher formed NMTC, Inc., which acquired a substantial portion of the assets of MTC, including the existing distributorship agreements of MTC.
In 1986, Danaher added Qualitrol to its instrumentation unit, including Gilbarco Veeder-Root's underground fuel storage sensors, Dynapar's motion sensors, and pressure measurement and temperature measurement instruments used on the electrical transformer industry.
1990–2000
In 1990, Danaher acquired Easco Hand Tools Inc. Danaher was selected as exclusive supplier of hand tools for Sears. In 1994, Danaher acquired Armstrong Tools, the makers of tool brands Armstrong, Allen, and others.
In 1995, Danaher acquired Hengstler GmbH, a manufacturer of counters, printers, relays, and high-precision rotational sensors. Hengstler was Danaher's first acquisition headquartered outside the United States.
In 1999, the company acquired Hach Company, involved in water and wastewater—and analytics, for $325 million.
2001–2010
In 2000, H. Lawrence Culp Jr. was named CEO of Danaher; he had joined the company in 1990.
Danaher acquired Trojan Technologies, an environmental engineering firm, in 2004.
Danaher also acquired UK-based West Instruments, which provides control and measurement instrumentation and services for the global industrial and process markets.
Danaher announced its agreement to acquire the Gendex division from DENTSPLY International on
December 11, 2003, with the acquisition closing in early 2004, integrating this dental imaging company into Danaher's growing dental portfolio.
PMA, a German manufacturer of control and measurement instrumentation, was acquired in April 2005.
In July 2005, Danaher acquired Leica Microsystems, which manufactures products for applications requiring microscopic imaging, measurement and analysis and offers management systems for biotechnology and medicine, as well as the science of raw materials and industrial quality assurance.
In early 2007, Danaher acquired Vision Systems, which manufactures and markets automated instruments, antibodies and biochemical reagents for biopsy-based detection of cancer and infectious diseases, for $520 million.
In July 2007, Danaher acquired ChemTreat.
In November 2007, Danaher purchased Tektronix for US$2.85 billion.
In 2009, Danaher acquired the Analytical Technologies business unit of MDS, including a 50% interest in AB SCIEX, for US$650 million. In February 2010, Danaher acquired the remaining 50% ownership position in AB SCIEX from Life Technologies for US$450 million.
2011–2020
In 2011, Danaher acquired Beckman Coulter, which was divided into a diagnostics segment and a life sciences segment.
In January 2012, Danaher sold Accu-sort to Datalogic.
In December 2012, Danaher acquired Navman Wireless, a provider of on-demand fleet and asset management technology.
In February 2013, Danaher and Cooper Industries sold their joint venture, Apex Tool Group, to Bain Capital for $1.6 billion.
In September 2014, Danaher acquired Nobel Biocare for $2.2 billion.
Effective March 1, 2015, H. Lawrence Culp Jr. resigned as CEO of Danaher.
In July 2015, Danaher combined its communications unit with NetScout Systems.
In August 2015, Danaher acquired Pall Corporation for $13.8 billion.
In June 2016, Danaher completed the corporate spin-off of Fortive, which included Matco and AMMCO-COATS. In September of the same year, the company announced it would acquire Cepheid for $4 billion including debt.
In October 2016, Danaher acquired Phenomenex for $700 million to expand in life sciences.
In October 2017, Danaher announced the acquisition of scientific informatics company ID Business Solutions Ltd. (IDBS). IDBS became part of Danaher's Life Sciences platform.
In March 2018, Danaher acquired Integrated DNA Technologies for an estimated $1.9 billion.
In July 2018, Danaher announced its intention to spin off its Dental segment into a public company, later named Envista Holdings Corporation. The corporate spin-off was completed in December 2019.
In March 2020, Integrated DNA Technologies, a subsidiary of the company, manufactured components for COVID-19 testing.
In March 2020, Danaher acquired the biopharma business of General Electric, a global provider of technologies and services related to the development, manufacture, and delivery of vaccines, diagnostics, and therapeutics to customers in organizations including academia, biotechnology, and drug manufacturing, for $21.4 billion and was rebranded as Cytiva. The GE deal raised monopoly concerns. The Federal Trade Commission conditionally approved the deal on the grounds that Danaher sold some biotechnology assets. In a second deal, Danaher's biomolecular characterization, chromatography hardware and resins, microcarriers and particle validation standards businesses were sold to Sartorius AG for approximately $825 million. The Cytiva name is derived from 'cyto' meaning 'cell' in Greek, and 'iva' a Latin suffix meaning 'doing' and 'capable of'.
Effective September 2020, Tom Joyce retired as CEO of the company; he was replaced by Executive Vice President Rainer Blair.
2021–present
In June 2021, Precision Nanosystems was acquired by Cytiva.
In August 2021, Danaher acquired Aldevron, which produces mRNA and proteins used in mRNA vaccines, for $9.6 billion in cash.
In May 2023, Pall Corporation merged with Cytiva to create a new Biotechnology Group within Danaher; at that time Cytiva employed more than 16,000 associates in over 40 countries.
Also in September 2022, Danaher announced its intention to spin off its Environmental & Applied Solutions segment; in February 2023, it was named Veralto and the corporate spin-off was completed in September 2023. The division included Aquatic Informatics, ChemTreat, Esko, Hach Company, Linx, McCrometer, OTT HydroMet, Pantone, Sea-Bird Scientific, Trojan Technologies, Videojet, XOS, and X-Rite.
In December 2023, Danaher acquired Abcam for approximately $5.7 billion.
In June 2024, the Food and Drug Administration granted marketing approval to Danaher's Cepheid unit for a rapid test for hepatitis C. Using a blood sample from a fingertip, the rapid test detects the virus's RNA and delivers results in less than roughly an hour, as opposed to requiring a sample to be sent to a lab.
In August 2024, the company acquired GeneData. In February 2026, Danaher announced it would acquire Masimo for $10 billion.
Divisions
Life sciences
Abcam
Beckman Coulter - Life Sciences
Cytiva
Integrated DNA Technologies
Leica Microsystems
Molecular Devices
Pall Corporation
SCIEX
Diagnostics
Beckman Coulter - Diagnostics
Cepheid
Leica Biosystems
Radiometer
Source: Wikipedia, CC BY-SA 4.0 · View on Wikipedia ↗
10-Year Performance Revenue, net income, margins and EPS trends
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | DHR | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E (TTM) | 38.25Y avg ≈36.6 | ≈36.6 | 32.0 | Overvalued | |
| P/S (TTM) | 6.05Y avg ≈7.1 | ≈7.1 | 5.4 | Fair value | |
| P/B (MRQ) | 2.95Y avg ≈3.5 | ≈3.5 | 6.9 | Undervalued | |
| Price / FCF (TTM) | 27.75Y avg ≈28.9 | ≈28.9 | · | · | |
| Price / Cash Flow (TTM) | 22.85Y avg ≈23.8 | ≈23.8 | 25.7 | Fair value | |
| Price / Tangible Book (MRQ) | 4.9 | · | · | · | |
| PEG Ratio | ≈58.8 | · | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | DHR | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Gross Margin (TTM) | 58.5%5Y avg ≈59.7% | ≈59.7% | 57.6% | In line | |
| Operating Margin (TTM) | 20.4%5Y avg ≈22.8% | ≈22.8% | 18.0% | In line | |
| EBITDA Margin | 19.1%5Y avg ≈27.5% | ≈27.5% | 18.3% | Weak | |
| Pretax Margin (TTM) | 19.0%5Y avg ≈22.0% | ≈22.0% | 18.9% | In line | |
| Net Profit Margin (TTM) | 15.9%5Y avg ≈19.1% | ≈19.1% | 15.8% | Weak | |
| ROA (TTM) | 4.6%5Y avg ≈6.3% | ≈6.3% | 11.5% | Weak | |
| ROE (TTM) | 7.6%5Y avg ≈10.8% | ≈10.8% | 18.4% | Weak | |
| ROIC | 5.6%5Y avg ≈7.7% | ≈7.7% | 13.8% | Weak |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | DHR | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Debt / Equity (MRQ) | 0.55Y avg ≈0.4 | ≈0.4 | 0.4 | High debt | |
| Current Ratio (MRQ) | 1.75Y avg ≈1.7 | ≈1.7 | 1.7 | In line | |
| Quick Ratio | 0.65Y avg ≈0.5 | ≈0.5 | 0.8 | Low liquidity | |
| Long-Term Debt / Equity (MRQ) | 0.55Y avg ≈0.4 | ≈0.4 | 0.4 | In line |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
| Metric | 5Y trend | DHR | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Revenue YoY | 2.9%5Y avg ≈2.2% | ≈2.2% | · | · | |
| Revenue CAGR 3Y | -2.7%5Y avg ≈-0.53% | ≈-0.53% | · | · | |
| Revenue CAGR 5Y | 2.0% | · | · | · | |
| EPS YoY | -4.5%5Y avg ≈6.5% | ≈6.5% | · | · | |
| Net Income YoY | -7.3%5Y avg ≈5.8% | ≈5.8% | · | · | |
| EPS CAGR 3Y | -19.4%5Y avg ≈-8.4% | ≈-8.4% | · | · | |
| EPS CAGR 5Y | 0.65% | · | · | · | |
| Net Income CAGR 3Y | -20.6%5Y avg ≈-8.9% | ≈-8.9% | · | · | |
| Net Income CAGR 5Y | -0.18% | · | · | · |
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
| Metric | 5Y trend | DHR | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Asset Turnover | 0.35Y avg ≈0.3 | ≈0.3 | 0.6 | Weak | |
| Inventory Turnover | 4.25Y avg ≈4.1 | ≈4.1 | 3.3 | Top tier | |
| Receivables Turnover | 6.65Y avg ≈6.5 | ≈6.5 | 5.3 | Top tier | |
| Revenue / Employee | ≈$423.6K | · | · | · |
value · ≈ 5Y avg · industry median · verdict relative to median
Dividends Yield, payout ratio, dividend history, 5Y CAGR
| Ex-date | Amount | Currency | Yield |
|---|---|---|---|
| Sep 30, 2026 | $0.40 | USD | ≈0.69% |
| Jun 26, 2026 | $0.40 | USD | ≈0.73% |
| Mar 27, 2026 | $0.40 | USD | ≈0.75% |
| Dec 26, 2025 | $0.32 | USD | ≈0.56% |
| Sep 26, 2025 | $0.32 | USD | ≈0.67% |
| Jun 27, 2025 | $0.32 | USD | ≈0.59% |
| Mar 28, 2025 | $0.32 | USD | ≈0.55% |
| Dec 27, 2024 | $0.27 | USD | ≈0.47% |
| Sep 27, 2024 | $0.27 | USD | ≈0.38% |
| Jun 28, 2024 | $0.27 | USD | ≈0.42% |
| Mar 27, 2024 | $0.27 | USD | ≈0.41% |
| Dec 28, 2023 | $0.24 | USD | ≈0.42% |
| Oct 11, 2023 | $0.27 | USD | ≈0.45% |
| Jun 29, 2023 | $0.24 | USD | ≈0.44% |
| Mar 30, 2023 | $0.24 | USD | ≈0.41% |
| Dec 29, 2022 | $0.22 | USD | ≈0.37% |
| Sep 29, 2022 | $0.22 | USD | ≈0.37% |
| Jun 23, 2022 | $0.22 | USD | ≈0.36% |
| Mar 24, 2022 | $0.22 | USD | ≈0.31% |
| Dec 29, 2021 | $0.19 | USD | ≈0.26% |
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Jul 20, 2026 | $1.94 | $1.85 | 4.7% |
| March 31, 2026 | $2.06 | $1.96 | 5.3% | |
| Dec. 31, 2025 | $2.23 | $2.17 | 2.6% | |
| Sept. 30, 2025 | $1.89 | $1.74 | 8.7% | |
| June 30, 2025 | $1.80 | $1.66 | 8.4% | |
| March 31, 2025 | $1.88 | $1.66 | 13.3% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $24.57B | $23.88B | $23.89B | $26.64B | $24.80B | $22.28B | $17.91B | $17.05B | $15.52B | $16.88B | $14.43B | $12.87B | |
| Cost of Revenue | $10.04B | $9.67B | $9.86B | $10.46B | $9.56B | $9.81B | $7.93B | $7.54B | $6.95B | $7.55B | $6.66B | $6.02B | |
| Gross Profit | $14.52B | $14.21B | $14.03B | $16.19B | $15.24B | $12.47B | $9.98B | $9.51B | $8.57B | $9.33B | $7.77B | $6.85B | |
| R&D Expense | $1.60B | $1.58B | $1.50B | $1.53B | $1.50B | $1.35B | $1.13B | $1.06B | $956M | $975M | $861M | $769M | |
| SG&A Expense | $8.23B | $7.76B | $7.33B | $7.12B | $6.82B | $6.90B | $5.59B | $5.39B | $5.04B | $5.62B | $4.75B | $4.04B | |
| Operating Income | $4.69B | $4.86B | $5.20B | $7.54B | $6.38B | $4.23B | $3.27B | $3.06B | $2.57B | $2.74B | $2.16B | $2.04B | |
| Interest Expense | · | · | $286M | $204M | $231M | $275M | $108M | $137M | $140M | $184M | $140M | $95M | |
| Interest Income | $30M | $117M | $303M | $41M | $11M | $71M | $139M | $9M | $8M | $200.0K | $5M | $13M | |
| Other Non-op | $-222M | $-56M | $-175M | $-227M | $450M | $494M | $12M | $35M | · | · | · | · | |
| Pretax Income | $4.23B | $4.65B | $5.04B | $7.15B | $6.51B | $4.50B | $3.31B | $2.96B | $2.54B | $2.61B | $2.04B | $2.09B | |
| Income Tax | $633M | $747M | $823M | $818M | $1.06B | $849M | $873M | $556M | $371M | $458M | $293M | $448M | |
| Net Income | $3.61B | $3.90B | $4.76B | $7.21B | $6.43B | $3.65B | $3.01B | $2.65B | $2.49B | $2.55B | $3.36B | $2.60B | |
| EPS (Basic) | $5.07 | $5.33 | $6.44 | $9.80 | $8.77 | $4.97 | $4.11 | $3.78 | $3.58 | $3.69 | $4.81 | $3.70 | |
| EPS (Diluted) | $5.05 | $5.29 | $6.38 | $9.66 | $8.61 | $4.89 | $4.05 | $3.74 | $3.53 | $3.65 | $4.74 | $3.63 | |
| Shares (Basic) | 712,700,000 | 731,000,000 | 736,500,000 | 725,100,000 | 714,600,000 | 706,200,000 | 715,000,000 | 700,600,000 | 695,800,000 | 691,200,000 | 698,100,000 | 702,200,000 | |
| Shares (Diluted) | 716,100,000 | 737,200,000 | 743,100,000 | 737,100,000 | 736,800,000 | 718,700,000 | 725,500,000 | 710,200,000 | 706,100,000 | 699,800,000 | 708,500,000 | 716,100,000 | |
| EBITDA | $4.69B | $4.86B | $7.37B | $10.91B | $9.63B | $6.01B | $4.46B | $4.71B | $4.26B | $3.88B | $4.52B | $4.37B |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | · | · | · | · | · | · | $19.91B | $788M | $630M | $964M | $791M | $3.01B | |
| Receivables | $3.91B | $3.54B | $3.92B | $4.10B | $4.63B | $4.04B | $3.19B | $3.03B | $3.52B | $3.19B | $2.99B | $3.45B | |
| Inventory | $2.49B | $2.33B | $2.59B | $2.77B | $2.77B | $2.29B | $1.63B | $1.63B | $1.84B | $1.71B | $1.57B | $1.78B | |
| Prepaid Expense | $1.74B | $1.55B | $1.56B | $1.74B | $1.66B | $1.43B | $865M | $858M | $857M | $806M | $890M | $953M | |
| Current Assets | $12.76B | $9.50B | $13.94B | $15.88B | $11.65B | $13.80B | $25.60B | $7.09B | $6.85B | $6.67B | $7.84B | $9.43B | |
| PP&E (Net) | $5.53B | $4.99B | $4.55B | $3.71B | $3.53B | $3.26B | $2.30B | $2.25B | $2.22B | $2.35B | $2.30B | $1.67B | |
| PP&E (Gross) | $10.30B | $9.09B | $8.38B | $7.14B | $7.25B | $6.44B | $5.06B | $4.70B | $4.97B | $4.32B | $3.99B | $4.71B | |
| Accum. Depreciation | $4.77B | $4.10B | $3.83B | $3.43B | $3.46B | $3.18B | $2.76B | $2.45B | $2.52B | $1.96B | $1.69B | $2.54B | |
| Goodwill | $43.15B | $40.50B | $41.61B | $37.28B | $38.68B | $35.42B | $22.71B | $22.58B | $21.77B | $23.83B | $21.01B | $11.58B | |
| Intangibles | $17.82B | $18.57B | $20.75B | $19.82B | $22.84B | $21.28B | $9.75B | $10.28B | $11.67B | $11.82B | $10.55B | $7.06B | |
| Other Non-current Assets | $4.21B | $3.99B | $3.64B | $4.16B | $3.72B | $2.40B | $1.72B | $571M | $538M | $631M | $845M | $1.02B | |
| Total Assets | $83.46B | $77.54B | $84.49B | $84.35B | $83.18B | $76.16B | $62.08B | $47.83B | $46.65B | $45.30B | $48.22B | $36.99B | |
| Accrued Liabilities | $4.96B | $4.54B | $4.81B | $4.82B | $5.56B | $5.34B | $3.21B | $2.69B | $3.09B | $2.79B | $2.61B | $3.19B | |
| Short-term Debt | · | · | · | · | · | · | · | · | · | · | · | $765M | |
| Current Liabilities | $6.81B | $6.80B | $8.27B | $8.39B | $8.14B | $7.40B | $4.93B | $4.84B | $4.79B | $6.87B | $6.17B | $5.40B | |
| Capital Leases | $1.08B | $968M | $954M | $772M | $889M | $785M | $639M | $0 | · | · | · | · | |
| Other Non-current Liabilities | $5.70B | $5.69B | $6.02B | $6.50B | $7.70B | $7.79B | $5.35B | $4.70B | $5.16B | $5.67B | $5.75B | $4.58B | |
| Long-term Debt | $18.42B | $16.00B | $18.40B | $19.68B | $22.18B | $21.20B | $21.73B | $9.74B | $10.52B | $12.27B | $12.87B | $3.47B | |
| Total Debt | $18.42B | $15.50B | $16.71B | $19.09B | $22.17B | $21.19B | $21.52B | $9.69B | $10.33B | $9.67B | $12.03B | $4.17B | |
| Common Stock | $9M | $9M | $9M | $9M | $9M | $9M | $8M | $8M | $8M | $8M | $8M | $8M | |
| Retained Earnings | $46.89B | $44.19B | $41.07B | $39.20B | $32.83B | $27.16B | $24.17B | $25.16B | $22.81B | $20.70B | $21.01B | $20.32B | |
| Treasury Stock | $11.35B | $8.16B | $2.02B | · | · | · | · | · | · | · | · | · | |
| AOCI | $-207M | $-3.22B | $-1.75B | $-2.87B | $-1.03B | $-368M | $-3.07B | $-2.79B | $-2.15B | $-3.02B | $-2.31B | $-1.43B | |
| Stockholders' Equity | $52.53B | $49.54B | $53.49B | $50.08B | $45.17B | $39.77B | $30.27B | $28.21B | $26.36B | $23.00B | $23.69B | $23.38B | |
| Liabilities + Equity | $83.46B | $77.54B | $84.49B | $84.35B | $83.18B | $76.16B | $62.08B | $47.83B | $46.65B | $45.30B | $48.22B | $36.99B | |
| Shares Outstanding | 706,900,000 | 719,100,000 | 739,200,000 | 728,300,000 | 715,000,000 | 711,000,000 | 695,500,000 | 701,500,000 | 696,600,000 | 692,200,000 | 686,800,000 | 704,300,000 |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | $2.17B | $2.13B | $2.06B | $1.77B | $1.19B | $1.18B | $1.12B | $1.13B | $881M | $718M | |
| Stock-based Comp | $298M | $288M | $306M | $295M | $184M | $187M | $159M | $138M | $127M | $130M | $104M | $85M | |
| Amort. of Intangibles | $1.70B | $1.63B | $1.49B | $1.43B | $1.39B | $1.14B | $625M | $616M | $579M | $583M | $397M | $269M | |
| Restructuring | · | · | · | · | · | · | · | $70M | $159M | $152M | $98M | $102M | |
| Other Non-cash | · | · | $-72M | $-1.25B | $-461M | $600M | $-405M | $-88M | $-392M | $-290M | $-746M | $100M | |
| Operating Cash Flow | $6.42B | $6.69B | $7.16B | $8.52B | $8.36B | $6.21B | $3.95B | $4.02B | $3.48B | $3.52B | $3.80B | $3.76B | |
| CapEx | $1.16B | $1.39B | $1.38B | $1.12B | $1.24B | $791M | $636M | $584M | $571M | $590M | $513M | $465M | |
| Investing Cash Flow | $-1.20B | $-1.98B | $-7.08B | $-2.23B | $-12.99B | $-21.24B | $-1.24B | $-2.95B | $-843M | $-5.24B | $-14.95B | $-3.44B | |
| Debt Issued | · | · | · | · | · | · | $12.11B | $0 | $1.78B | $3.24B | $5.68B | $0 | |
| Net Debt Issued | · | · | · | · | · | · | $10.55B | $-508M | $1.11B | $760M | $5.65B | $-415M | |
| Stock Issued | · | · | · | $0 | $0 | $1.73B | $1.44B | $0 | $0 | $164M | $249M | $133M | |
| Stock Repurchased | $3.09B | $5.98B | $0 | $0 | · | · | · | · | · | · | · | $0 | |
| Net Stock Activity | $-3.09B | $-5.98B | · | $0 | $0 | $1.73B | $1.44B | $96M | $69M | $164M | $249M | $133M | |
| Dividends Paid | $878M | $768M | $821M | $818M | $742M | $615M | $527M | $433M | $378M | $400M | $354M | $228M | |
| Financing Cash Flow | $-2.96B | $-8.38B | $-273M | $-2.57B | $1.29B | $1.01B | $16.36B | $-797M | $-3.10B | $2.04B | $9.05B | $-218M | |
| Net Change in Cash | $2.54B | $-3.79B | $-131M | $3.41B | $-3.45B | $-13.88B | $19.12B | $158M | $-333M | $173M | $-2.21B | $-110M | |
| Taxes Paid | $1.20B | $1.30B | $1.80B | $1.80B | $1.70B | · | · | · | · | · | · | · | |
| Free Cash Flow | $5.26B | $5.30B | $5.78B | $7.37B | $7.06B | $5.42B | $3.32B | $3.37B | $2.86B | $2.93B | $3.17B | $3.16B | |
| Levered FCF | · | · | $5.54B | $7.18B | $6.87B | $5.19B | $3.24B | $3.24B | $2.72B | $2.78B | $3.04B | $3.07B |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 59.1% | 59.5% | 58.7% | 60.2% | 61.0% | 56.0% | 55.7% | 55.8% | 55.6% | 55.3% | 52.3% | 52.4% | |
| Operating Margin | 19.1% | 20.4% | 21.8% | 27.6% | 25.4% | 19.0% | 18.2% | 17.1% | 16.5% | 16.3% | 16.9% | 17.2% | |
| Net Margin | 14.7% | 16.3% | 19.9% | 22.9% | 21.8% | 16.4% | 16.8% | 13.3% | 13.6% | 15.1% | 16.3% | 13.1% | |
| Pretax Margin | 17.2% | 19.5% | 21.1% | 26.4% | 25.8% | 20.2% | 18.4% | 16.6% | 16.0% | 15.5% | 16.2% | 17.5% | |
| EBITDA Margin | 19.1% | 20.4% | 30.8% | 34.7% | 32.7% | 27.0% | 24.9% | 23.7% | 23.2% | 23.0% | 22.0% | 21.9% | |
| ROA | 4.5% | 4.8% | 5.6% | 8.6% | 8.1% | 5.3% | 5.5% | 5.6% | 5.4% | 5.5% | 7.9% | 7.2% | |
| ROE | 7.1% | 7.6% | 9.2% | 15.1% | 15.2% | 10.4% | 10.3% | 9.7% | 10.1% | 10.9% | 14.3% | 11.4% | |
| ROIC | 5.6% | 6.3% | 6.2% | 10.9% | 9.3% | 5.6% | 4.7% | 7.2% | 6.9% | 6.9% | 7.6% | 9.3% |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.9 | 1.4 | 1.7 | 1.9 | 1.4 | 1.9 | 5.2 | 1.5 | 1.4 | 1.0 | 1.3 | 1.7 | |
| Quick Ratio | 0.6 | 0.5 | 0.5 | 0.6 | 0.6 | 0.5 | 4.7 | 0.9 | 0.9 | 0.6 | 0.8 | 1.2 | |
| Debt / Equity | 0.4 | 0.3 | 0.3 | 0.4 | 0.5 | 0.5 | 0.7 | 0.3 | 0.4 | 0.4 | 0.5 | 0.2 | |
| LT Debt / Equity | 0.4 | 0.3 | 0.3 | 0.4 | 0.5 | 0.5 | 0.7 | 0.3 | 0.4 | 0.4 | 0.5 | 0.1 | |
| Interest Coverage | · | · | 18.2 | 41.2 | 31.4 | 15.4 | 30.1 | 21.6 | 18.6 | 14.9 | 21.3 | 28.0 |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.3 | 0.3 | 0.4 | 0.4 | 0.3 | 0.3 | 0.4 | 0.4 | 0.4 | 0.5 | 0.6 | |
| Inventory Turnover | 4.2 | 3.9 | 3.7 | 4.3 | 4.5 | 5.0 | 4.9 | 4.7 | 4.6 | 4.6 | 5.1 | 5.2 | |
| Receivables Turnover | 6.6 | 6.4 | 6.0 | 6.6 | 6.8 | 6.2 | 5.8 | 5.7 | 5.5 | 5.5 | 5.6 | 5.6 |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $74.32 | $68.90 | $72.36 | $68.77 | $63.17 | $55.93 | $43.52 | $40.22 | $37.84 | $33.23 | $34.49 | $33.19 | |
| Revenue / Share | $34.31 | $32.39 | $32.15 | $42.70 | $39.97 | $31.01 | $24.69 | $28.01 | $25.96 | $24.12 | $29.02 | $27.81 | |
| Cash Flow / Share | $8.96 | $9.07 | $9.64 | $11.56 | $11.34 | $8.64 | $5.45 | $5.66 | $4.93 | $5.03 | $5.37 | $5.25 | |
| Cash / Share | · | · | · | · | · | · | $28.63 | $1.12 | $0.90 | $1.39 | $1.15 | $4.27 | |
| EPS (TTM) | $5.05 | $5.29 | $6.38 | $9.66 | $8.61 | $4.89 | $4.05 | $3.74 | $3.53 | $3.65 | $4.74 | $3.63 |
Growth Rates
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 2.9% | -0.06% | -10.3% | 7.4% | 11.3% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -2.7% | -1.3% | 2.4% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 2.0% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -4.5% | -17.1% | -34.0% | 12.2% | 76.1% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | -19.4% | -15.0% | 9.3% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 0.65% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -7.3% | -18.2% | -33.9% | 12.1% | 76.4% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | -20.6% | -15.4% | 9.3% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -0.18% | · | · | · | · | · | · | · | · | · | · | · | |
| Dividends Paid CAGR 5Y | 7.4% | · | · | · | · | · | · | · | · | · | · | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $24.57B | $23.88B | $23.89B | $26.64B | $24.80B | $22.28B | $17.91B | $17.05B | $15.52B | $16.88B | $14.43B | $12.87B | |
| Net Income TTM | $3.61B | $3.90B | $4.76B | $7.21B | $6.43B | $3.65B | $3.01B | $2.65B | $2.49B | $2.55B | $3.36B | $2.60B | |
| Market Cap | $161.82B | $165.07B | $171.01B | $171.37B | $208.55B | $140.02B | $94.63B | $64.13B | $57.32B | $47.77B | $56.55B | $53.52B | |
| Enterprise Value | · | · | · | · | · | · | $96.24B | $73.03B | $67.02B | $56.48B | $67.79B | $54.68B | |
| P/E | 45.3 | 43.4 | 36.3 | 24.4 | 33.9 | 40.3 | 33.6 | 24.4 | 23.3 | 18.9 | 17.4 | 20.9 | |
| P/S | 6.6 | 6.9 | 7.2 | 6.4 | 8.4 | 6.3 | 5.3 | 3.8 | 3.7 | 2.8 | 3.9 | 4.2 | |
| P/B | 3.1 | 3.3 | 3.2 | 3.4 | 4.6 | 3.5 | 3.1 | 2.3 | 2.2 | 2.1 | 2.4 | 2.3 | |
| P / Cash Flow | 25.2 | 24.7 | 23.9 | 20.1 | 25.0 | 22.6 | 23.9 | 15.9 | 16.5 | 13.6 | 14.9 | 14.2 | |
| P / FCF | 30.8 | 31.2 | 29.6 | 23.3 | 29.5 | 25.8 | 28.5 | 19.1 | 20.1 | 16.3 | 17.8 | 16.9 | |
| EV / EBITDA | · | · | · | · | · | · | 21.6 | 15.5 | 15.7 | 14.6 | 15.0 | 12.5 | |
| EV / FCF | · | · | · | · | · | · | 29.0 | 21.7 | 23.4 | 19.3 | 21.4 | 17.3 | |
| EV / Revenue | · | · | · | · | · | · | 5.4 | 4.3 | 4.3 | 3.3 | 4.7 | 4.2 | |
| Dividend Yield | 0.54% | 0.47% | 0.48% | 0.48% | 0.36% | 0.44% | 0.56% | 0.68% | 0.66% | 0.84% | 0.63% | 0.43% | |
| Earnings Yield | 2.2% | 2.3% | 2.8% | 4.1% | 2.9% | 2.5% | 3.0% | 4.1% | 4.3% | 5.3% | 5.8% | 4.8% | |
| Payout Ratio | 24.3% | 19.7% | 17.2% | 11.3% | 11.5% | 16.9% | 17.5% | 16.4% | 15.2% | 15.7% | 10.5% | 8.8% | |
| Annual Payout | $878M | $768M | $821M | $818M | $742M | $615M | $527M | $433M | $378M | $400M | $354M | $228M |
Income Statement
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $6.26B | $5.95B | $6.84B | $6.05B | $5.94B | $5.74B | $6.54B | $5.80B | $5.74B | $5.80B | $6.41B | $5.62B | $5.91B | $5.95B | $3.54B | $6.46B | |
| Cost of Revenue | $2.65B | $2.36B | $2.87B | $2.53B | $2.41B | $2.23B | $2.65B | $2.40B | $2.31B | $2.31B | $2.63B | $2.35B | $2.59B | $2.29B | $1.36B | $3.08B | |
| Gross Profit | $3.61B | $3.59B | $3.97B | $3.52B | $3.52B | $3.51B | $3.89B | $3.40B | $3.43B | $3.49B | $3.78B | $3.27B | $3.32B | $3.66B | $2.18B | $3.89B | |
| R&D Expense | $412M | $387M | $438M | $378M | $403M | $379M | $442M | $383M | $391M | $368M | $407M | $362M | $361M | $373M | $236M | $420M | |
| SG&A Expense | $2.07B | $1.86B | $2.03B | $1.99B | $2.36B | $1.86B | $2.02B | $2.06B | $1.87B | $1.81B | $2.04B | $1.73B | $1.79B | $1.77B | $798M | $2.15B | |
| Operating Income | $1.13B | $1.34B | $1.50B | $1.15B | $760M | $1.27B | $1.43B | $958M | $1.17B | $1.31B | $1.34B | $1.19B | $1.16B | $1.52B | $1.14B | $1.72B | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $65M | · | $73M | $67M | $66M | · | $42M | |
| Interest Income | $61M | $27M | $13M | $3M | $8M | $6M | $14M | $4M | $39M | $60M | $117M | $79M | $59M | $48M | $29M | $9M | |
| Other Non-op | $-3M | $-73M | $-87M | $-14M | $-42M | $-79M | $-63M | $102M | $-59M | $-36M | $-137M | $-47M | $-15M | $24M | $-69M | $-51M | |
| Pretax Income | $1.08B | $1.24B | $1.37B | $1.08B | $655M | $1.13B | $1.31B | $977M | $1.08B | $1.27B | $1.23B | $1.15B | $1.14B | $1.52B | $1.05B | $1.93B | |
| Income Tax | $208M | $206M | $190M | $168M | $100M | $175M | $229M | $159M | $176M | $183M | $111M | $207M | $222M | $283M | $-304M | $359M | |
| Net Income | $870M | $1.03B | $1.20B | $908M | $555M | $954M | $1.09B | $818M | $907M | $1.09B | $1.08B | $1.13B | $1.11B | $1.45B | $2.23B | $1.57B | |
| EPS (Basic) | $1.23 | $1.45 | $1.69 | $1.28 | $0.77 | $1.33 | $1.50 | $1.13 | $1.23 | $1.47 | $1.45 | $1.53 | $1.50 | $1.96 | $3.04 | $2.13 | |
| EPS (Diluted) | $1.23 | $1.45 | $1.69 | $1.27 | $0.77 | $1.32 | $1.50 | $1.12 | $1.22 | $1.45 | $1.44 | $1.51 | $1.49 | $1.94 | $2.99 | $2.10 | |
| Shares (Basic) | 705,300,000 | 707,900,000 | · | 710,700,000 | 716,500,000 | 716,300,000 | · | 723,000,000 | 737,600,000 | 740,600,000 | · | 739,400,000 | 737,300,000 | 729,400,000 | · | 728,500,000 | |
| Shares (Diluted) | 707,600,000 | 711,200,000 | · | 713,700,000 | 719,100,000 | 720,800,000 | · | 729,400,000 | 742,400,000 | 748,600,000 | · | 745,900,000 | 744,700,000 | 737,200,000 | · | 737,400,000 | |
| EBITDA | · | $1.34B | · | $1.15B | $760M | $1.27B | · | $958M | $1.17B | $1.31B | · | $1.44B | $1.43B | $1.79B | · | $2.02B |
Balance Sheet
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Receivables | $3.96B | $3.82B | $3.91B | $3.75B | $3.56B | $3.51B | $3.54B | $3.51B | $3.30B | $3.38B | · | $4.20B | $4.20B | $4.31B | · | $4.41B | |
| Inventory | $3.26B | $2.61B | $2.49B | $2.67B | $2.69B | $2.53B | $2.33B | $2.68B | $2.67B | $2.65B | · | $3.02B | $3.18B | $3.38B | · | $3.24B | |
| Prepaid Expense | $1.81B | $1.81B | $1.74B | $1.65B | $1.79B | $1.49B | $1.55B | $1.25B | $1.27B | $1.32B | · | $1.70B | $1.50B | $1.46B | · | $1.46B | |
| Current Assets | $13.38B | $13.94B | $12.76B | $9.61B | $11.00B | $9.53B | $9.50B | $10.06B | $9.61B | $14.37B | · | $21.20B | $17.46B | $16.53B | · | $14.25B | |
| PP&E (Net) | $5.83B | $5.47B | $5.53B | $5.38B | $5.31B | $5.11B | $4.99B | $4.84B | $4.64B | $4.56B | $4.55B | $4.30B | $4.18B | $4.07B | $3.71B | $3.72B | |
| PP&E (Gross) | · | · | $10.30B | · | · | · | $9.09B | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | $4.92B | $4.83B | $4.77B | $4.67B | $4.56B | $4.31B | $4.10B | $4.20B | $4.05B | $3.96B | · | $4.12B | $4.12B | $4.02B | · | $3.63B | |
| Goodwill | $47.41B | $42.77B | $43.15B | $42.95B | $42.99B | $41.66B | $40.50B | $42.17B | $40.80B | $40.85B | $41.61B | $39.16B | $39.58B | $39.86B | $37.28B | $38.25B | |
| Intangibles | $21.36B | $17.17B | $17.82B | $18.10B | $18.63B | $18.89B | $18.57B | $19.85B | $19.55B | $19.89B | · | $18.79B | $19.32B | $19.98B | · | $19.96B | |
| Other Non-current Assets | $4.39B | $4.21B | $4.21B | $3.87B | $3.69B | $3.94B | $3.99B | $3.69B | $3.95B | $3.73B | · | $4.29B | $4.37B | $4.61B | · | $4.85B | |
| Total Assets | $92.37B | $83.54B | $83.46B | $79.90B | $81.62B | $79.12B | $77.54B | $80.61B | $78.56B | $83.40B | $84.49B | $87.73B | $84.90B | $85.04B | $84.35B | $81.03B | |
| Accrued Liabilities | $4.87B | $4.75B | $4.96B | $4.60B | $4.57B | $4.42B | $4.54B | $4.54B | $4.36B | $4.35B | · | $4.93B | $4.86B | $5.08B | · | $5.11B | |
| Current Liabilities | $8.11B | $7.46B | $6.81B | $6.32B | $6.79B | $6.64B | $6.80B | $7.34B | $6.70B | $7.78B | · | $9.37B | $8.40B | $8.73B | · | $8.00B | |
| Capital Leases | · | · | $1.08B | · | · | · | $968M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | $6.52B | $5.57B | $5.70B | $5.66B | $5.63B | $5.64B | $5.69B | $5.65B | $5.64B | $5.76B | · | $6.44B | $6.49B | $6.56B | · | $7.49B | |
| Long-term Debt | $26.56B | $18.48B | $18.42B | $16.86B | $17.36B | $16.48B | $16.00B | $17.52B | $17.01B | $18.16B | · | $22.06B | $19.88B | $19.83B | · | $19.25B | |
| Total Debt | · | $17.56B | · | $16.83B | $16.85B | $15.98B | · | $16.32B | $16.31B | $16.42B | · | $19.51B | $18.29B | $18.26B | · | $18.54B | |
| Common Stock | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | · | $9M | $9M | $9M | · | $9M | |
| Retained Earnings | $48.23B | $47.64B | $46.89B | $45.92B | $45.24B | $44.91B | $44.19B | $43.30B | $42.67B | $41.96B | · | $42.27B | $41.34B | $40.44B | · | $37.18B | |
| Treasury Stock | $12.32B | $11.41B | $11.35B | $11.34B | $9.30B | $9.31B | $8.16B | · | · | · | · | · | · | · | · | · | |
| AOCI | $-795M | $-593M | $-207M | $-590M | $-569M | $-1.61B | $-3.22B | $-1.31B | $-2.59B | $-2.74B | · | $-3.96B | $-3.58B | $-2.77B | $-2.87B | $-3.85B | |
| Stockholders' Equity | $52.58B | $52.95B | $52.53B | $51.07B | $52.33B | $50.85B | $49.54B | $51.30B | $49.90B | $53.44B | · | $52.41B | $51.72B | $51.48B | · | $46.98B | |
| Liabilities + Equity | $92.37B | $83.54B | $83.46B | $79.90B | $81.62B | $79.12B | $77.54B | $80.61B | $78.56B | $83.40B | · | $87.73B | $84.90B | $85.04B | · | $81.03B | |
| Shares Outstanding | 702,900,000 | 707,700,000 | 706,900,000 | 706,300,000 | 715,900,000 | 715,600,000 | 719,100,000 | 722,200,000 | 724,000,000 | 740,600,000 | · | 738,900,000 | 738,200,000 | 729,200,000 | · | 727,900,000 |
Cash Flow
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $93M | $58M | $63M | $83M | $91M | $61M | $57M | $84M | $87M | $60M | $61M | $57M | $87M | $70M | $25M | $89M | |
| Amort. of Intangibles | $463M | $434M | $428M | $433M | $426M | $410M | $408M | $414M | $402M | $407M | $380M | $343M | $360M | $372M | $314M | $361M | |
| Operating Cash Flow | $1.53B | $1.32B | $2.12B | $1.66B | $1.34B | $1.30B | $2.02B | $1.51B | $1.42B | $1.74B | $1.62B | $1.67B | $1.93B | $1.95B | $2.54B | $2.01B | |
| CapEx | $269M | $237M | $371M | $292M | $248M | $245M | $516M | $298M | $287M | $291M | $434M | $333M | $320M | $266M | $295M | $277M | |
| Investing Cash Flow | $-10.15B | $-249M | $-384M | $-312M | $-258M | $-242M | $-694M | $-606M | $-360M | $-321M | $-6.02B | $-329M | $-431M | $-304M | $-816M | $-515M | |
| Stock Repurchased | $894M | $0 | $0 | $2.01B | $0 | $1.08B | $809M | $640M | $4.53B | $0 | $0 | $0 | · | · | · | · | |
| Net Stock Activity | · | $0 | · | · | · | $-1.08B | · | · | · | · | · | · | · | · | · | · | |
| Dividends Paid | $283M | $226M | $226M | $229M | $229M | $194M | $195M | $196M | $200M | $177M | $200M | $199M | $218M | $204M | $203M | $204M | |
| Financing Cash Flow | $7.27B | $46M | $1.32B | $-2.78B | $-247M | $-1.25B | $-1.69B | $-845M | $-5.71B | $-133M | $-2.25B | $2.44B | $-208M | $-262M | $-906M | $-230M | |
| Net Change in Cash | $-1.35B | $1.09B | $3.09B | $-1.43B | $964M | $-85M | $-549M | $253M | $-4.66B | $1.17B | $-6.41B | $3.70B | $1.20B | $1.38B | $845M | $1.17B | |
| Taxes Paid | $350M | $191M | $392M | $277M | $330M | $201M | $367M | $315M | $396M | $222M | $630M | $476M | $466M | $228M | $706M | $469M | |
| Free Cash Flow | · | $1.08B | · | · | · | $1.05B | · | · | · | $1.45B | · | · | · | $1.67B | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $1.39B | · | · | · | $1.62B | · | · |
Profitability
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | 60.3% | · | 58.2% | 59.4% | 61.2% | · | 58.7% | 59.7% | 60.2% | · | 58.2% | 56.5% | 61.0% | · | 59.8% | |
| Operating Margin | · | 22.6% | · | 19.1% | 12.8% | 22.2% | · | 16.5% | 20.3% | 22.6% | · | 20.9% | 20.0% | 25.0% | · | 26.3% | |
| Net Margin | 13.9% | 17.3% | · | 15.0% | 9.3% | 16.6% | · | 14.1% | 15.8% | 18.8% | · | 16.4% | 15.4% | 20.2% | · | 20.5% | |
| Pretax Margin | 17.2% | 20.8% | · | 17.8% | 11.0% | 19.7% | · | 16.9% | 18.9% | 21.9% | · | 20.3% | 19.4% | 25.1% | · | 25.2% | |
| EBITDA Margin | 18.0% | 22.6% | · | 19.1% | 12.8% | 22.2% | · | 16.5% | 20.3% | 22.6% | · | 20.9% | 20.0% | 25.0% | · | 26.3% | |
| ROA | 1.0% | 1.3% | · | 1.1% | 0.69% | 1.2% | · | 0.97% | 1.1% | 1.3% | · | 1.3% | 1.3% | 1.7% | · | 1.9% | |
| ROE | 1.7% | 2.0% | · | 1.8% | 1.1% | 1.8% | · | 1.6% | 1.8% | 2.1% | · | 2.3% | 2.2% | 3.0% | · | 3.5% | |
| ROIC | 1.2% | 1.6% | · | 1.4% | 0.93% | 1.6% | · | 1.2% | 1.5% | 1.6% | · | 1.6% | 1.6% | 2.1% | · | 2.5% |
Liquidity & Solvency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.7 | 1.9 | · | 1.5 | 1.6 | 1.4 | · | 1.4 | 1.4 | 1.8 | · | 2.3 | 2.1 | 1.9 | · | 1.8 | |
| Quick Ratio | 0.5 | 0.5 | · | 0.6 | 0.5 | 0.5 | · | 0.5 | 0.5 | 0.4 | · | 0.4 | 0.5 | 0.5 | · | 0.6 | |
| Debt / Equity | 0.5 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.4 | 0.4 | 0.4 | · | 0.4 | |
| LT Debt / Equity | 0.5 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.4 | 0.4 | 0.4 | · | 0.4 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 20.2 | · | 19.7 | 21.3 | 26.4 | · | 48.0 |
Efficiency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.9 | 0.9 | · | 0.9 | 0.9 | 0.9 | · | 0.8 | 0.8 | 0.8 | · | 0.9 | 1.0 | 0.9 | · | 1.2 | |
| Receivables Turnover | · | 1.6 | · | 1.7 | 1.7 | 1.7 | · | 1.5 | 1.5 | 1.5 | · | 1.6 | 1.6 | 1.6 | · | 1.8 |
Per Share
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $74.81 | $74.82 | · | $72.31 | $73.10 | $71.06 | · | $71.03 | $68.92 | $72.16 | · | $70.93 | $70.06 | $70.60 | · | $64.55 | |
| Revenue / Share | $8.85 | $8.37 | · | $8.48 | $8.25 | $7.96 | · | $7.95 | $7.74 | $7.74 | · | $9.21 | $9.61 | $9.72 | · | $10.39 | |
| Cash Flow / Share | · | $1.86 | · | · | · | $1.80 | · | · | · | $2.32 | · | · | · | $2.64 | · | · | |
| EPS (TTM) | $5.64 | $5.18 | · | $4.86 | $4.71 | $5.16 | · | $5.23 | $5.62 | $5.89 | · | $7.93 | $8.52 | $9.28 | · | $9.05 |
Valuation (TTM)
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $25.11B | $24.78B | · | $24.27B | $24.01B | $23.82B | · | $23.74B | $23.57B | $23.74B | · | $21.03B | $21.86B | $22.47B | · | $23.01B | |
| Net Income TTM | $4.00B | $3.69B | · | $3.50B | $3.41B | $3.77B | · | $3.89B | $4.20B | $4.40B | · | $5.92B | $6.36B | $6.93B | · | $6.76B | |
| Market Cap | $137.90B | $128.46B | · | $130.55B | $142.32B | $147.31B | · | $198.92B | $180.89B | $184.94B | · | $162.52B | $157.06B | $162.93B | · | $166.67B | |
| P/E | 34.8 | 35.0 | · | 38.0 | 42.2 | 39.9 | · | 52.7 | 44.5 | 42.4 | · | 27.7 | 25.0 | 24.1 | · | 25.3 | |
| P/S | 5.5 | 5.2 | · | 5.4 | 5.9 | 6.2 | · | 8.4 | 7.7 | 7.8 | · | 7.7 | 7.2 | 7.3 | · | 7.2 | |
| P/B | 2.6 | 2.4 | · | 2.6 | 2.7 | 2.9 | · | 3.9 | 3.6 | 3.5 | · | 3.1 | 3.0 | 3.2 | · | 3.5 | |
| P / Cash Flow | · | 97.2 | · | · | · | 113.4 | · | · | · | 106.3 | · | · | · | 83.7 | · | · | |
| Dividend Yield | 0.70% | 0.71% | · | 0.65% | 0.57% | 0.53% | · | 0.39% | 0.43% | 0.43% | · | 0.51% | 0.53% | · | · | · | |
| Earnings Yield | 2.9% | 2.9% | · | 2.6% | 2.4% | 2.5% | · | 1.9% | 2.2% | 2.4% | · | 3.6% | 4.0% | 4.2% | · | 4.0% | |
| Payout Ratio | · | 22.0% | · | · | · | 20.3% | · | · | · | 16.3% | · | · | · | 14.1% | · | · | |
| Annual Payout | · | $910M | · | $847M | $814M | $785M | · | $773M | $776M | $794M | · | $824M | $829M | · | · | · |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Revenue | $24.57B | $23.88B | $23.89B | $26.64B | $24.80B |
| Gross Margin % | 59.1% | 59.5% | 58.7% | 60.2% | 61.0% |
| Operating Margin % | 19.1% | 20.4% | 21.8% | 27.6% | 25.4% |
| Net Income | $3.61B | $3.90B | $4.76B | $7.21B | $6.43B |
| Diluted EPS | $5.05 | $5.29 | $6.38 | $9.66 | $8.61 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Debt / Equity | 0.4 | 0.3 | 0.3 | 0.4 | 0.5 |
| Current Ratio | 1.9 | 1.4 | 1.7 | 1.9 | 1.4 |
| Quick Ratio | 0.6 | 0.5 | 0.5 | 0.6 | 0.6 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Free Cash Flow | $5.26B | $5.30B | $5.78B | $7.37B | $7.06B |
Institutional owners (13F) 2,312 filers · $121.1B total · As of Sept. 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 148 (-60 vs prior Q) | 182 (-73 vs prior Q) | 694 (-87 vs prior Q) | 1,024 (+88 vs prior Q) | -368K |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| VANGUARD GROUP INC | $13,959,166,172 | 60,978,360 | 11.52% | Shares |
| BlackRock, Inc. | $10,492,520,322 | 55,084,630 | 8.66% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $7,881,505,437 | 41,377,076 | 6.51% | Shares |
| FMR LLC | $5,626,949,757 | 29,540,895 | 4.65% | Shares |
| STATE STREET CORP | $5,431,565,288 | 28,456,019 | 4.48% | Shares |
| WELLINGTON MANAGEMENT GROUP LLP | $3,108,030,541 | 16,316,834 | 2.57% | Shares |
| Capital International Investors | $2,953,960,497 | 15,504,420 | 2.44% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $2,707,246,740 | 14,280,335 | 2.23% | Shares |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2,705,808,973 | 14,205,213 | 2.23% | Shares |
| JPMORGAN CHASE & CO | $2,349,101,825 | 12,185,400 | 1.94% | Shares |
| MORGAN STANLEY | $2,161,750,127 | 11,348,958 | 1.78% | Shares |
| Capital Research Global Investors | $2,060,650,455 | 10,818,030 | 1.70% | Shares |
| NORGES BANK | $1,816,780,335 | 9,537,906 | 1.50% | Shares |
| EAGLE CAPITAL MANAGEMENT LLC | $1,783,176,557 | 9,361,490 | 1.47% | Shares |
| NORTHERN TRUST CORP | $1,319,158,000 | 6,925,441 | 1.09% | Shares |
| GENERATION INVESTMENT MANAGEMENT LLP | $1,287,948,806 | 6,761,596 | 1.06% | Shares |
| JANUS HENDERSON GROUP PLC | $1,222,064,214 | 6,489,965 | 1.01% | Shares |
| GOLDMAN SACHS GROUP INC | $1,021,898,650 | 5,364,861 | 0.84% | Shares |
| Nuveen, LLC | $998,625,469 | 5,242,679 | 0.82% | Shares |
| BANK OF AMERICA CORP /DE/ | $993,845,921 | 5,217,586 | 0.82% | Shares |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $990,823,246 | 5,225,861 | 0.82% | Shares |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $983,459,478 | 5,163,059 | 0.81% | Shares |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $979,232,536 | 5,140,868 | 0.81% | Shares |
| Fisher Asset Management, LLC | $854,260,080 | 4,484,774 | 0.71% | Shares |
| Legal & General Group Plc | $801,056,220 | 4,205,461 | 0.66% | Shares |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $762,216,330 | 3,878,641 | 0.63% | Shares |
| Invesco Ltd. | $753,537,418 | 3,955,992 | 0.62% | Shares |
| FLOSSBACH VON STORCH SE | $747,259,707 | 3,923,035 | 0.62% | Shares |
| Bank of New York Mellon Corp | $712,874,853 | 3,742,518 | 0.59% | Shares |
| FRANKLIN RESOURCES INC | $702,374,137 | 3,687,390 | 0.58% | Shares |
| PARNASSUS INVESTMENTS, LLC | $699,862,950 | 3,674,207 | 0.58% | Shares |
| Holocene Advisors, LP | $684,356,163 | 3,592,798 | 0.56% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $674,795,972 | 3,542,608 | 0.56% | Shares |
| UBS Group AG | $617,826,451 | 3,243,524 | 0.51% | Shares |
| Amundi | $549,255,875 | 2,883,536 | 0.45% | Shares |
| PRINCIPAL FINANCIAL GROUP INC | $507,487,046 | 2,664,239 | 0.42% | Shares |
| DIMENSIONAL FUND ADVISORS LP | $505,131,601 | 2,651,651 | 0.42% | Shares |
| AQR CAPITAL MANAGEMENT LLC | $503,199,762 | 2,641,746 | 0.42% | Shares |
| BROWN ADVISORY INC | $500,677,350 | 2,628,487 | 0.41% | Shares |
| ROYAL BANK OF CANADA | $455,982,000 | 2,393,859 | 0.38% | Shares |
| DEUTSCHE BANK AG\ | $446,265,498 | 2,342,847 | 0.37% | Shares |
| AMERIPRISE FINANCIAL INC | $444,130,104 | 2,331,466 | 0.37% | Shares |
| FIL Ltd | $442,569,613 | 2,323,444 | 0.37% | Shares |
| D1 Capital Partners L.P. | $434,682,789 | 2,282,039 | 0.36% | Shares |
| FIRST MANHATTAN CO. LLC. | $429,106,102 | 2,248,424 | 0.35% | Shares |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $410,455,346 | 2,154,842 | 0.34% | Shares |
| MILLENNIUM MANAGEMENT LLC | $407,739,012 | 2,140,587 | 0.34% | Shares |
| Castle Hook Partners LP | $404,836,478 | 2,125,349 | 0.33% | Shares |
| CIBC Private Wealth Group LLC | $402,413,634 | 2,029,727 | 0.33% | Shares |
| WELLS FARGO & COMPANY/MN | $401,433,291 | 2,107,482 | 0.33% | Shares |
Activists & 5%+ owners 9 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Mitchell P. Rales ×9 filings | Nov. 2, 2021 | · | Initial filing | · | SEC |
| Steven M. Rales ×6 filings | June 14, 2021 | · | Initial filing | · | SEC |
| Undisclosed reporting person | Oct. 22, 2014 | · | Initial filing | M&A / sale | SEC |
| Danaher Corporation., Aegean Acquisition Corp. ×2 filings | Dec. 9, 2010 | · | Initial filing | · | SEC |
| Danaher Corporation, DH Holdings Corp., DH Technologies Development Pte. Ltd. ×3 filings | Feb. 5, 2010 | · | Initial filing | · | SEC |
| Equity Group Holdings LLC, Equity Group Holdings II LLC, Steven M. Rales, Mitchell P. Rales ×6 filings | March 30, 2007 | · | Initial filing | · | SEC |
| Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person | April 23, 2003 | · | Initial filing | · | SEC |
| Undisclosed reporting person, Undisclosed reporting person | June 8, 2001 | · | Initial filing | · | SEC |
| Undisclosed reporting person | May 25, 2001 | · | Initial filing | M&A / sale | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 50 insiders · 24 officers · 12 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Rainer Blair | President & CEO | Aug. 21, 2026 S | 0 | 0 | 3 | $-12,736,069 |
| Thomas Patrick Joyce JR | President and CEO | July 24, 2020 M | 203,513 | 0 | 0 | $0 |
| Lawrence H Culp JR | President and CEO | July 18, 2014 M | 512,199 | 0 | 0 | $0 |
| Georgeann Couchara | SVP, Human Resources | May 15, 2026 F | 8,291 | 0 | 2 | $-1,088,686 |
| Matthew Mcgrew | Executive Vice President | March 1, 2026 A | 26,825 | 0 | 1 | $-3,470,835 |
| Bradley R Gray | SVP Strategic Development | March 1, 2026 A | 14,463 | 0 | 0 | $0 |
| Brian W Ellis | Senior Vice President | Feb. 4, 2026 A | 14,994 | 0 | 2 | $-4,773,810 |
| Daniel Raskas | SVP - Corporate Development | Feb. 1, 2025 A | 10,524 | 0 | 0 | $0 |
| William King | SVP, Strategic Development | May 15, 2024 M | 48,190 | 0 | 0 | $0 |
| Joakim Weidemanis | Executive Vice President | May 15, 2024 F | 87,333 | 0 | 0 | $0 |
| Jennifer Honeycutt | Executive Vice President | May 15, 2023 F | 26,165 | 0 | 0 | $0 |
| Angela S Lalor | SVP, Human Resources | Feb. 24, 2022 A | 47,962 | 0 | 0 | $0 |
| Robert S Lutz | SVP-Chief Accounting Officer | Aug. 13, 2021 M | 16,155 | 0 | 0 | $0 |
| William K Daniel | EVP | Feb. 20, 2020 A | 109,886 | 0 | 0 | $0 |
| James A Lico | Executive Vice President | May 10, 2016 A | 113,198 | 0 | 0 | $0 |
| Mark A Beck | Executive Vice President | July 28, 2015 S | 0 | 0 | 0 | $0 |
| Jonathan P Graham | Senior VP & GC | May 19, 2015 M | 34,606 | 0 | 0 | $0 |
| James H Ditkoff | Senior VP-Finance & Tax | Feb. 21, 2015 F | 174,406 | 0 | 0 | $0 |
| Philip Knisely | Executive Vice President | Jan. 29, 2010 A | 5,010 | 0 | 0 | $0 |
| Steve Simms | Executive Vice President | Oct. 26, 2007 A | 4,400 | 0 | 0 | $0 |
| Patrick W Allender | Executive VP | Feb. 1, 2007 M | 75,813 | 0 | 0 | $0 |
| Daniel A Pryor | VP-Strategic Development | May 4, 2005 A | 0 | 0 | 0 | $0 |
| Donald E Doles | VP-Danaher Business System | Aug. 31, 2004 A | · | 0 | 0 | $0 |
| Chris Mcmahon | VP -- Controller | Jan. 1, 2004 A | 0 | 0 | 0 | $0 |
| Charles W Lamanna | Director | May 15, 2026 A | 1,359 | 0 | 0 | $0 |
| John T Schwieters | Director | July 15, 2025 M | 19,815 | 0 | 0 | $0 |
| Jessica L Mega | Director | May 15, 2025 A | 3,302 | 0 | 0 | $0 |
| Pardis C Sabeti | Director | Oct. 25, 2024 A | 5,283 | 0 | 0 | $0 |
| Walter G Lohr | Director | Feb. 15, 2024 M | 14,129 | 0 | 0 | $0 |
| Donald J Ehrlich | Director | Feb. 10, 2020 M | 123,203 | 0 | 0 | $0 |
| Robert J Hugin | Director | May 15, 2017 A | 3,576 | 0 | 0 | $0 |
| Mortimer M Caplin | Director | April 26, 2013 A | 83,213 | 0 | 0 | $0 |
| Emmet A Stephenson JR | Director | Nov. 30, 2007 M | 368,240 | 0 | 0 | $0 |
| Matthew E Gugino | · | Aug. 4, 2026 A | 11,401 | 0 | 0 | $0 |
| Gregory M Milosevich | · | Aug. 4, 2026 A | 24,467 | 0 | 1 | $-274,573 |
| Montgomery Julie A Sawyer | · | Aug. 4, 2026 A | 22,221 | 0 | 0 | $0 |
| Christopher Paul Riley | · | Aug. 4, 2026 A | 61,472 | 0 | 0 | $0 |
| Christopher Bouda | · | Aug. 4, 2026 A | 9,107 | 0 | 0 | $0 |
| Jose-Carlos Gutierrez-Ramos | · | Aug. 4, 2026 A | 32,495 | 0 | 0 | $0 |
| Jonathan Leiken | · | Aug. 4, 2026 A | 12,546 | 0 | 0 | $0 |
| Mitchell P. Rales | · | Aug. 4, 2026 A | 553,228 | 0 | 9 | $-234,561,260 |
| Steven M Rales | · | Aug. 4, 2026 A | 3,605,808 | 0 | 0 | $0 |
| Shane A Sanders | · | July 31, 2026 A | 5,914 | 0 | 0 | $0 |
| Raymond C Stevens | · | July 31, 2026 A | 13,728 | 0 | 0 | $0 |
| Teri List-Stoll | · | July 31, 2026 A | 21,470 | 0 | 1 | $-746,997 |
| Feroz Dewan | · | July 31, 2026 A | 4,686 | 0 | 0 | $0 |
| Elias A. Zerhouni | · | July 31, 2026 A | 45,303 | 0 | 0 | $0 |
| Linda P Hefner | · | July 31, 2026 A | 26,829 | 0 | 0 | $0 |
| Alan G Spoon | · | July 31, 2026 A | 124,774 | 0 | 1 | $-237,202 |
| Daniel L Comas | · | Oct. 23, 2020 M | 92,683 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 125 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| JXX · Janus Detroit Street Trust | 4.03% | 5,508 NS | July 31, 2026 | N-PORT |
| EQTY · Valued Advisers Trust | 3.22% | 235,300 NS | July 31, 2026 | N-PORT |
| ASLV · ALLSPRING EXCHANGE-TRADED FUNDS TRU… | 2.62% | 29,365 NS | July 31, 2026 | N-PORT |
| JDOC · J.P. Morgan Exchange-Traded Fund Tr… | 2.16% | 1,006 NS | July 31, 2026 | N-PORT |
| IYH · iShares Trust | 2.04% | 369,897 SH | Sept. 11, 2026 | Daily |
| GRW · TCW ETF Trust | 1.92% | 6,380 NS | July 31, 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 1.80% | 302,986 NS | July 31, 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 1.79% | 1,914,802 SH | Aug. 19, 2026 | Daily |
| RSPH · Invesco Exchange-Traded Fund Trust | 1.73% | 70,526 SH | Oct. 5, 2026 | Daily |
| MEDI · Harbor ETF Trust | 1.73% | 3,647 NS | July 31, 2026 | N-PORT |
| HTEC · EXCHANGE TRADED CONCEPTS TRUST | 1.67% | 5,923 NS | July 31, 2026 | N-PORT |
| IXJ · iShares Trust | 1.60% | 331,014 SH | Sept. 11, 2026 | Daily |
| CURE · Direxion Shares ETF Trust | 1.41% | 12,395 NS | July 31, 2026 | N-PORT |
| NULV · Nushares ETF Trust | 1.30% | 147,190 NS | July 31, 2026 | N-PORT |
| NULC · Nushares ETF Trust | 1.15% | 4,154 NS | July 31, 2026 | N-PORT |
| PEXL · Pacer Funds Trust | 1.13% | 2,932 NS | July 31, 2026 | N-PORT |
| AGRW · ALLSPRING EXCHANGE-TRADED FUNDS TRU… | 1.10% | 6,377 NS | July 31, 2026 | N-PORT |
| TGLB · T. Rowe Price Exchange-Traded Funds… | 1.07% | 1,437 NS | July 31, 2026 | N-PORT |
| EQWL · Invesco Exchange-Traded Fund Trust | 1.06% | 137,672 SH | Oct. 5, 2026 | Daily |
| BKDV · BNY Mellon ETF Trust II | 1.03% | 96,880 NS | July 31, 2026 | N-PORT |
| WINN · Harbor ETF Trust | 0.81% | 46,812 NS | July 31, 2026 | N-PORT |
| BIGY · Tidal Trust II | 0.79% | 2,199 NS | July 31, 2026 | N-PORT |
| XT · iShares Trust | 0.72% | 138,670 SH | Sept. 11, 2026 | Daily |
| FFLC · FIDELITY COVINGTON TRUST | 0.59% | 36,489 NS | July 31, 2026 | N-PORT |
| IIGD · Invesco Exchange-Traded Self-Indexe… | 0.58% | 165,000 | Oct. 5, 2026 | Daily |
| MGV · VANGUARD WORLD FUND | 0.57% | 400,375 SH | Aug. 19, 2026 | Daily |
| PFM · Invesco Exchange-Traded Fund Trust | 0.55% | 20,005 SH | Oct. 5, 2026 | Daily |
| VIG · VANGUARD SPECIALIZED FUNDS | 0.52% | 3,558,711 SH | Aug. 19, 2026 | Daily |
| USXF · iShares Trust | 0.51% | 37,795 SH | Sept. 11, 2026 | Daily |
| IWX · iShares Trust | 0.47% | 91,310 SH | Sept. 11, 2026 | Daily |
| VTV · VANGUARD INDEX FUNDS | 0.45% | 6,058,224 SH | Aug. 19, 2026 | Daily |
| QUVU · Hartford Funds Exchange-Traded Trust | 0.44% | 4,091 NS | July 31, 2026 | N-PORT |
| EVUS · iShares Trust | 0.43% | 8,232 SH | Sept. 11, 2026 | Daily |
| FXH · First Trust Exchange-Traded AlphaDE… | 0.43% | 23,256 NS | July 31, 2026 | N-PORT |
| IVE · iShares Trust | 0.42% | 1,046,214 SH | Sept. 11, 2026 | Daily |
| VOOV · VANGUARD ADMIRAL FUNDS | 0.41% | 145,011 SH | Aug. 19, 2026 | Daily |
| IUSV · iShares Trust | 0.40% | 551,533 SH | Sept. 11, 2026 | Daily |
| ILCV · iShares Trust | 0.38% | 25,086 SH | Sept. 11, 2026 | Daily |
| SUSL · iShares Trust | 0.37% | 22,482 SH | Sept. 11, 2026 | Daily |
| CHRI · Global X Funds | 0.37% | 153 NS | July 31, 2026 | N-PORT |
| DSI · iShares Trust | 0.36% | 97,358 SH | Sept. 11, 2026 | Daily |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0.36% | 16,095 SH | Oct. 5, 2026 | Daily |
| DFUV · Dimensional ETF Trust | 0.35% | 277,749 NS | July 31, 2026 | N-PORT |
| IWD · iShares Trust | 0.34% | 1,404,243 SH | Sept. 11, 2026 | Daily |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0.34% | 381,505 SH | Aug. 19, 2026 | Daily |
| SUSA · iShares Trust | 0.29% | 58,103 SH | Sept. 11, 2026 | Daily |
| OEF · iShares Trust | 0.27% | 266,715 SH | Sept. 11, 2026 | Daily |
| PFIG · Invesco Exchange-Traded Fund Trust … | 0.25% | 346,000 | Oct. 5, 2026 | Daily |
| VFVA · VANGUARD WELLINGTON FUND | 0.25% | 11,236 SH | Aug. 19, 2026 | Daily |
| DFLV · Dimensional ETF Trust | 0.24% | 84,826 NS | July 31, 2026 | N-PORT |
| DGRO · iShares Trust | 0.24% | 521,760 SH | Sept. 11, 2026 | Daily |
| USCL · iShares Trust | 0.24% | 33,717 SH | Sept. 11, 2026 | Daily |
| TOPC · iShares Trust | 0.23% | 381 SH | Sept. 11, 2026 | Daily |
| MGC · VANGUARD WORLD FUND | 0.23% | 127,343 SH | Aug. 19, 2026 | Daily |
| ACVF · ETF Opportunities Trust | 0.23% | 1,783 NS | July 31, 2026 | N-PORT |
| QVML · Invesco Exchange-Traded Fund Trust … | 0.23% | 17,906 SH | Oct. 5, 2026 | Daily |
| IWL · iShares Trust | 0.22% | 24,594 SH | Sept. 11, 2026 | Daily |
| PRF · Invesco Exchange-Traded Fund Trust | 0.22% | 102,567 SH | Oct. 5, 2026 | Daily |
| SIZE · iShares Trust | 0.22% | 4,614 SH | Sept. 11, 2026 | Daily |
| XVV · iShares Trust | 0.22% | 7,252 SH | Sept. 11, 2026 | Daily |
| RSP · Invesco Exchange-Traded Fund Trust | 0.21% | 950,514 SH | Oct. 5, 2026 | Daily |
| ESGV · VANGUARD WORLD FUND | 0.21% | 142,869 SH | Aug. 19, 2026 | Daily |
| PBUS · Invesco Exchange-Traded Fund Trust … | 0.21% | 102,791 SH | Oct. 5, 2026 | Daily |
| PBP · Invesco Exchange-Traded Fund Trust | 0.21% | 3,722 SH | Oct. 5, 2026 | Daily |
| JPUS · J.P. Morgan Exchange-Traded Fund Tr… | 0.20% | 4,805 NS | July 31, 2026 | N-PORT |
| ILCB · iShares Trust | 0.20% | 12,530 SH | Sept. 11, 2026 | Daily |
| BBUS · J.P. Morgan Exchange-Traded Fund Tr… | 0.19% | 88,851 NS | July 31, 2026 | N-PORT |
| VOTE · TCW ETF Trust | 0.19% | 10,899 NS | July 31, 2026 | N-PORT |
| EUSA · iShares, Inc. | 0.19% | 18,450 SH | Sept. 11, 2026 | Daily |
| IVV · iShares Trust | 0.19% | 7,939,826 SH | Sept. 11, 2026 | Daily |
| VOXP · Advisors Series Trust | 0.19% | 57 NS | July 31, 2026 | N-PORT |
| XCLR · Global X Funds | 0.19% | 35 NS | July 31, 2026 | N-PORT |
| PTLC · Pacer Funds Trust | 0.19% | 31,952 NS | July 31, 2026 | N-PORT |
| XRMI · Global X Funds | 0.19% | 489 NS | July 31, 2026 | N-PORT |
| XYLD · Global X Funds | 0.19% | 31,674 NS | July 31, 2026 | N-PORT |
| XTR · Global X Funds | 0.19% | 47 NS | July 31, 2026 | N-PORT |
| VOO · VANGUARD INDEX FUNDS | 0.19% | 16,363,510 SH | Aug. 19, 2026 | Daily |
| VV · VANGUARD INDEX FUNDS | 0.19% | 743,939 SH | Aug. 19, 2026 | Daily |
| TOV · EA Series Trust | 0.19% | 2,581 NS | July 31, 2026 | N-PORT |
| BKLC · BNY Mellon ETF Trust | 0.19% | 53,257 NS | July 31, 2026 | N-PORT |
| ADME · ETF Series Solutions | 0.19% | 2,836 NS | July 31, 2026 | N-PORT |
| ACIO · ETF Series Solutions | 0.19% | 22,752 NS | July 31, 2026 | N-PORT |
| XYLG · Global X Funds | 0.19% | 616 NS | July 31, 2026 | N-PORT |
| IWB · iShares Trust | 0.18% | 437,462 SH | Sept. 11, 2026 | Daily |
| IYY · iShares Trust | 0.18% | 27,014 SH | Sept. 11, 2026 | Daily |
| PEVC · Pacer Funds Trust | 0.18% | 22 NS | July 31, 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0.18% | 189,347 NS | July 31, 2026 | N-PORT |
| SPUU · Direxion Shares ETF Trust | 0.18% | 2,377 NS | July 31, 2026 | N-PORT |
| IWV · iShares Trust | 0.17% | 174,302 SH | Sept. 11, 2026 | Daily |
| QDPL · Pacer Funds Trust | 0.17% | 15,178 NS | July 31, 2026 | N-PORT |
| BSCT · Invesco Exchange-Traded Self-Indexe… | 0.17% | 5,511,000 | Oct. 5, 2026 | Daily |
| ITOT · iShares Trust | 0.17% | 820,097 SH | Sept. 11, 2026 | Daily |
| VTI · VANGUARD INDEX FUNDS | 0.17% | 20,226,391 SH | Aug. 19, 2026 | Daily |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0.17% | 104,620 SH | Aug. 19, 2026 | Daily |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.17% | 53,219 SH | Aug. 19, 2026 | Daily |
| ESGU · iShares Trust | 0.17% | 151,590 SH | Sept. 11, 2026 | Daily |
| PHDG · Invesco Actively Managed Exchange-T… | 0.17% | 493 SH | Oct. 5, 2026 | Daily |
| TILT · FlexShares Trust | 0.16% | 18,486 NS | July 31, 2026 | N-PORT |
| TOK · iShares Trust | 0.15% | 1,797 SH | Sept. 11, 2026 | Daily |
| HCMT · Direxion Shares ETF Trust | 0.15% | 4,381 NS | July 31, 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0.15% | 17,583 NS | July 31, 2026 | N-PORT |
| CRBN · iShares Trust | 0.15% | 8,649 SH | Sept. 11, 2026 | Daily |
| OMFL · Invesco Exchange-Traded Self-Indexe… | 0.14% | 31,801 SH | Oct. 5, 2026 | Daily |
| SPXL · Direxion Shares ETF Trust | 0.14% | 49,245 NS | July 31, 2026 | N-PORT |
| URTH · iShares, Inc. | 0.14% | 56,946 SH | Sept. 11, 2026 | Daily |
| RWL · Invesco Exchange-Traded Fund Trust … | 0.13% | 61,158 SH | Oct. 5, 2026 | Daily |
| DFAU · Dimensional ETF Trust | 0.13% | 83,138 NS | July 31, 2026 | N-PORT |
| ACWI · iShares Trust | 0.12% | 201,808 SH | Sept. 11, 2026 | Daily |
| DCOR · Dimensional ETF Trust | 0.12% | 20,495 NS | July 31, 2026 | N-PORT |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0.10% | 3,770 SH | Oct. 5, 2026 | Daily |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0.10% | 523,769 SH | Aug. 19, 2026 | Daily |
| FEX · First Trust Exchange-Traded AlphaDE… | 0.09% | 7,398 NS | July 31, 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0.08% | 206,412 NS | July 31, 2026 | N-PORT |
| FBCG · FIDELITY COVINGTON TRUST | 0.07% | 25,158 NS | July 31, 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0.05% | 1,457 NS | July 31, 2026 | N-PORT |
| DYNF · BlackRock ETF Trust | 0.05% | 104,339 SH | Sept. 11, 2026 | Daily |
| BLV · VANGUARD BOND INDEX FUNDS | · | · | July 15, 2026 | Daily |
| BSV · VANGUARD BOND INDEX FUNDS | · | · | July 15, 2026 | Daily |
| BND · VANGUARD BOND INDEX FUNDS | · | · | July 15, 2026 | Daily |
| VCSH · VANGUARD SCOTTSDALE FUNDS | · | · | July 15, 2026 | Daily |
| VCLT · VANGUARD SCOTTSDALE FUNDS | · | · | July 15, 2026 | Daily |
| VTC · VANGUARD SCOTTSDALE FUNDS | · | · | July 30, 2026 | Daily |
| BNDW · VANGUARD SCOTTSDALE FUNDS | · | · | July 30, 2026 | Daily |
| BNDX · VANGUARD CHARLOTTE FUNDS | · | · | July 15, 2026 | Daily |
| VCEB · VANGUARD WORLD FUND | · | · | July 30, 2026 | Daily |
DHR Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
12-Month Price Target
22 analysts · 2026-10-02Mean target $234.73 +8.9%
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| DHR | $161.82B | 45.3 | 2.9% | 14.7% | 7.1% | 59.1% |
| TMO | $257.86B | 32.7 | 3.9% | 15.0% | 13.0% | · |
| A | $41.43B | 32.0 | 6.7% | 18.8% | 20.6% | · |
| WAT | $22.62B | 35.3 | 7.0% | 20.3% | 27.2% | · |
| IQV | $38.23B | 28.8 | 5.9% | 8.3% | 21.6% | · |
| ILMN | $20.65B | 24.8 | -0.66% | 19.6% | 34.1% | 66.1% |
| MTD | $28.38B | 33.2 | 4.0% | 21.6% | -615.5% | 59.4% |
| WST | $19.81B | 40.5 | 6.2% | 16.1% | 16.2% | 35.9% |
| RVTY | $10.86B | 46.7 | 3.7% | 8.5% | 3.3% | · |
| MEDP | $15.93B | 36.8 | 20.0% | 17.8% | 142.9% | · |
| CRL | $10.02B | -70.0 | -0.85% | -3.6% | -4.4% | · |
Latest News Recent headlines mentioning this company
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.